510(k) Report

FDA applicant

Pentapharm, Ltd.

Washington, DC3 decisions2004–20102 recalls

FDA records 3 decisions for Pentapharm, Ltd. (Washington, DC) from 2004 to 2010: 3 510(k) clearances. Most are in product codes GGN (Plasma, Coagulation Control) and GGW (Test, Time, Partial Thromboplastin). Its devices cite 3 predicates, 0 of them its own earlier devices. 2 recalls are linked to its devices.

FDA’s records also spell it “Pentapharm GmbH”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, hematology panel, where it files most

How often FDA has decided Pentapharm, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2016

2014: 12016: 1
2007high 1 (2014) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Pentapharm, Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Pentapharm, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report